Core Viewpoint - A lawsuit has been filed against Evolv Technologies Holdings, Inc. and certain current and former executives due to alleged material misstatements in financial statements impacting revenue recognition and other metrics [1][3][4] Group 1: Lawsuit Details - The lawsuit is filed under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Evolv's securities [2] - The case is pending in the U.S. District Court for the District of Massachusetts, captioned Buchan v. Evolv Technologies Holdings, Inc., No. 1:24-cv-12768 [2] - Investors have until December 31, 2024, to request to be appointed to lead the case [2] Group 2: Financial Misstatements - Evolv's financial statements from Q2 2022 to Q2 2024 contained material misstatements regarding revenue recognition [3][4] - The company disclosed that certain sales were subject to extracontractual terms not communicated to accounting personnel, and misconduct was involved in these transactions [4] Group 3: Stock Price Impact - Following the announcement of the financial misstatements, Evolv's stock price dropped approximately 40%, from $4.10 on October 24, 2024, to $2.47 on October 25, 2024 [4] - After the termination of CEO Peter George on October 31, 2024, the stock price fell about 8%, from $2.34 on October 30, 2024, to $2.15 on October 31, 2024 [5] Group 4: Legal Representation - Bleichmar Fonti & Auld LLP, a leading law firm in securities class actions, is representing the plaintiffs in this case [7] - The firm operates on a contingency fee basis, meaning there are no upfront costs for shareholders [6]

NEW YORK, Nov. 8, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Evolv Technologies Holdings, Inc. ("Evolv Technologies Holdings, Inc." or the "Company") (NASDAQ: EVLV) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Evolv Technologies Holdings, Inc. investors who were adversely affected by alleged securities fraud between August 19, 2022 and October 30, 2024. Follow the link below to get more information and be contacted by a member ...

NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Evolv Technologies Holdings, Inc. ("Evolv Technologies" or "the Company") (NASDAQ: EVLV) and certain of its officers.Class DefinitionThis lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise ...

ATLANTA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Evolv Technologies Holdings, Inc. (“Evolv” or “the Company”) (NASDAQ: EVLV). The lawsuit alleges that Defendants made materially false and misleading statements and/or failed to disclose material adverse information, including allegations that Evolv’s sales, including sales to one of its largest channel partners, were subject to extra-contractual terms and conditions not shared with the Company’s accounting ...

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) securities between August 19, 2022 and October 30, 2024. Evolv is a security technology company that utilizes AI-based screening designed to help create safer experiences. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The ...

NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Evolv Technologies Holdings, Inc. (“Evolv” or the “Company”) (NASDAQ: EVLV) in the United States District Court for the District of Massachusetts on behalf of all persons and entities who purchased or otherwise acquired Evolv securities between August 19, 2022 and October 30, 2024, both dates inclusive (the “Class Period”). ...

NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of all persons or entities who purchased or otherwise acquired Evolv Technologies Holdings, Inc. (“Evolv Technologies” or the “Company”) (Nasdaq: EVLV) securities between August 19, 2022 and October 30, 2024, inclusive (the “Class Period”). The lawsuit seeks to recover damages for the Company’s in ...

Core Viewpoint - A lawsuit has been filed against Evolv Technologies Holdings, Inc. and certain current and former executives, alleging material misstatements in financial statements related to revenue recognition from Q2 2022 to Q2 2024 [1][2][3] Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Massachusetts, captioned Buchan v. Evolv Technologies Holdings, Inc., No. 1:24-cv-12768 [2] - Investors have until December 31, 2024, to request to lead the case [2] Group 2: Financial Misstatements - Evolv's financial statements from Q2 2022 to Q2 2024 contained material misstatements regarding revenue recognition and other metrics [3] - On October 25, 2024, Evolv announced that its financial statements should not be relied upon due to these misstatements, revealing issues with sales to a major channel partner and misconduct by certain personnel [4] Group 3: Stock Price Impact - Following the announcement of financial misstatements, Evolv's stock price dropped approximately 40%, from $4.10 on October 24, 2024, to $2.47 on October 25, 2024 [4] - After the termination of CEO Peter George on October 31, 2024, the stock price fell about 8%, from $2.34 on October 30, 2024, to $2.15 on October 31, 2024 [5] Group 4: Legal Representation - Bleichmar Fonti & Auld LLP is representing plaintiffs in this case, with no upfront costs for shareholders [6][7] - The firm has a strong track record, having recovered over $900 million from Tesla's Board of Directors and $420 million from Teva Pharmaceutical Industries [8]

Core Viewpoint - A lawsuit has been filed against Evolv Technologies Holdings, Inc. and certain current and former executives, alleging material misstatements in financial statements related to revenue recognition from Q2 2022 to Q2 2024 [1][2][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Massachusetts, captioned Buchan v. Evolv Technologies Holdings, Inc., No. 1:24-cv-12768 [2]. - Investors have until December 31, 2024, to request to be appointed to lead the case [2]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. Group 2: Financial Misstatements - Evolv's financial statements from Q2 2022 to Q2 2024 contained material misstatements regarding revenue recognition and other metrics [3]. - The company revealed that certain sales were subject to extracontractual terms not disclosed to accounting personnel, and misconduct was involved in these transactions [4]. Group 3: Stock Price Impact - Following the announcement of the financial misstatements, Evolv's stock price dropped approximately 40%, from $4.10 on October 24, 2024, to $2.47 on October 25, 2024 [4]. - After the termination of CEO Peter George on October 31, 2024, the stock price fell about 8%, from $2.34 on October 30, 2024, to $2.15 on October 31, 2024 [5]. Group 4: Company Background - Evolv Technologies is a security technology company that utilizes AI-based screening to enhance safety [3]. - The company has self-reported issues to the SEC and is delaying its upcoming quarterly report for Q3 2024 [4].

Core Viewpoint - A class action lawsuit has been filed against Evolv Technologies Holdings, Inc. due to allegations of misleading investors regarding revenue recognition and material misstatements in financial statements [1][2]. Group 1: Allegations and Financial Impact - Evolv Technologies announced on October 25, 2024, that its financial statements from Q2 2022 to Q2 2024 should not be relied upon due to material misstatements affecting revenue recognition [2]. - The company disclosed that certain sales, particularly to a major channel partner, involved undisclosed extra-contractual terms and conditions, leading to misconduct by some personnel [2]. - Following this announcement, Evolv's stock price plummeted approximately 40%, dropping from $4.10 per share on October 24, 2024, to $2.47 per share on October 25, 2024 [2]. Group 2: Class Action Participation - Shareholders who wish to serve as lead plaintiffs in the class action must submit their applications by December 31, 2024 [3]. - Participation in the case is not required to be eligible for recovery; shareholders can remain absent class members if they choose [3]. Group 3: Legal Representation - Robbins LLP operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless the case is won [4]. - Robbins LLP is recognized for its commitment to shareholder rights litigation and has recovered over $1 billion for shareholders since its inception [5].